• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.

作者信息

Auerbach Michael, Pappadakis Jennifer A, Bahrain Huzefa, Auerbach Sarah A, Ballard Harold, Dahl Naomi V

机构信息

Auerbach Hematology-Oncology, Baltimore, Maryland, USA.

出版信息

Am J Hematol. 2011 Oct;86(10):860-2. doi: 10.1002/ajh.22153. Epub 2011 Aug 29.

DOI:10.1002/ajh.22153
PMID:21922526
Abstract
摘要

相似文献

1
Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.快速静脉滴注（1小时）1克低分子右旋糖酐铁（INFeD）治疗缺铁性贫血的安全性和有效性。
Am J Hematol. 2011 Oct;86(10):860-2. doi: 10.1002/ajh.22153. Epub 2011 Aug 29.
2
Accelerated total dose infusion of low molecular weight iron dextran is safe and efficacious in chronic kidney disease patients.加速低分子右旋糖酐铁的总剂量输注在慢性肾脏病患者中是安全有效的。
QJM. 2011 Mar;104(3):221-30. doi: 10.1093/qjmed/hcq180. Epub 2010 Oct 18.
3
Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.静脉注射低分子右旋糖酐铁治疗口服铁剂无效的缺铁性贫血患儿。
Pediatr Blood Cancer. 2013 Nov;60(11):1747-52. doi: 10.1002/pbc.24676. Epub 2013 Jul 6.
4
Parenteral iron dextran therapy: a review.
Nutrition. 1995 Mar-Apr;11(2):163-8.
5
[Safety and efficacy of total dose intravenous iron infusion in the treatment of iron-deficiency anemia in adult non-pregnant patients].静脉注射铁剂全剂量治疗成年非妊娠缺铁性贫血患者的安全性和有效性
Rev Invest Clin. 2002 Jan-Feb;54(1):12-20.
6
The safety of intravenous iron dextran (Dexferrum) during hemodialysis in patients with end stage renal disease.终末期肾病患者血液透析期间静脉注射右旋糖酐铁（Dexferrum）的安全性。
Nephrol Nurs J. 2000 Feb;27(1):41-2.
7
Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia.右旋糖酐铁总剂量输注治疗缺铁性贫血的安全性和有效性。
Int J Clin Pract. 2008 Mar;62(3):413-5. doi: 10.1111/j.1742-1241.2007.01401.x. Epub 2007 Nov 12.
8
Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.慢性肾脏病中静脉注射蔗糖铁与低分子右旋糖酐铁的比较
J Ren Care. 2009 Jun;35(2):67-73. doi: 10.1111/j.1755-6686.2009.00099.x.
9
[Parenteral iron replacement].
Praxis (Bern 1994). 1997 May 14;86(20):835-6.
10
Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia.老年慢性肾脏病合并缺铁性贫血患者静脉输注右旋糖酐铁总剂量的安全性
Ren Fail. 2014 Aug;36(7):1033-7. doi: 10.3109/0886022X.2014.918785. Epub 2014 May 21.

引用本文的文献

1
Evaluation of Different Polysaccharide-Iron Complex Preparations In Vitro and In Vivo.不同多糖铁复合物制剂的体内外评价
Pharmaceutics. 2025 Feb 23;17(3):292. doi: 10.3390/pharmaceutics17030292.
2
Optimization of micelle-encapsulated extremely small sized iron oxide nanoparticles as a T1 contrast imaging agent: biodistribution and safety profile.优化胶束包裹的超小尺寸氧化铁纳米颗粒作为T1对比成像剂：生物分布和安全性概况。
J Nanobiotechnology. 2024 Jul 16;22(1):419. doi: 10.1186/s12951-024-02699-8.
3
How I treat bleeding in hereditary hemorrhagic telangiectasia.
我如何治疗遗传性出血性毛细血管扩张症的出血。
Blood. 2024 Aug 29;144(9):940-954. doi: 10.1182/blood.2023021765.
4
A Survey on the implementation of Patient Blood Management programs in Italy.意大利患者血液管理项目实施情况调查
Blood Transfus. 2025 May-Jun;23(3):223-231. doi: 10.2450/BloodTransfus.724. Epub 2024 Mar 28.
5
IV iron formulations and use in adults.静脉铁剂制剂及在成人中的应用。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):622-629. doi: 10.1182/hematology.2023000495.
6
Response of the Endogenous Antioxidant Defense System Induced in RAW 264.7 Macrophages upon Exposure to Dextran-Coated Iron Oxide Nanoparticles.RAW 264.7巨噬细胞暴露于葡聚糖包被的氧化铁纳米颗粒后内源性抗氧化防御系统的反应。
Pharmaceutics. 2023 Feb 7;15(2):552. doi: 10.3390/pharmaceutics15020552.
7
In Vitro and In Vivo Biological Assays of Dextran Coated Iron Oxide Aqueous Magnetic Fluids.葡聚糖包被的氧化铁水性磁流体的体外和体内生物学测定
Pharmaceutics. 2023 Jan 4;15(1):177. doi: 10.3390/pharmaceutics15010177.
8
Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management experts.成人上消化道出血时红细胞输注及铁剂补充的指征与血红蛋白阈值：胃肠病学家及患者血液管理专家提出的一项算法
Front Med (Lausanne). 2022 Sep 15;9:903739. doi: 10.3389/fmed.2022.903739. eCollection 2022.
9
Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions.成人既往输注反应史与无既往输注反应史患者的不良事件与静脉铁剂制剂分析。
JAMA Netw Open. 2022 Mar 1;5(3):e224488. doi: 10.1001/jamanetworkopen.2022.4488.
10
Development of Pharmaceutical Nanomedicines: From the Bench to the Market.药物纳米医学的发展：从实验室到市场
Pharmaceutics. 2022 Jan 3;14(1):106. doi: 10.3390/pharmaceutics14010106.